Bolt Biotherapeutics, Inc. BOLT
Set alert
6.24 USD -0.35 -5.31%
At close · Nov 2
6.24 0.00 0.00%
After hours · Nov 2, 4:00 PM ET
6.18 Day range 6.58
3.18 52-week range 7.09
- YTD
- +14.08%
- 1 year
- +8.33%
- Open
- 6.58
- Prev close
- 6.59
- Mkt cap
- 14.71M
- Vol
- 50.40K
- Avg vol
- 243.87K
- EPS
- -15.73
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 6.18
- High
- 6.58
- Forward P/E
- -0.40
- Beta
- 0.92
- Short ratio
- 0.54
- Inst. own
- 58.19%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Aug 13, 2024
- 50-d avg
- 0.60464
- 200-d avg
- 0.795015
- 1y target
- 1.75
5D chart
Signals (122)
| Name | Time | Ago |
|---|---|---|
| SMA: Bearish | Nov 2, 2:30 PM | 11 hours ago |
| RSI: Oversold | Nov 2, 2:30 PM | 11 hours ago |
| MACD: Sell Signal | Nov 2, 1:40 PM | 12 hours ago |
| SMA: Bearish | Nov 2, 1:25 PM | 12 hours ago |
| SMA: Bullish | Nov 2, 12:30 PM | 13 hours ago |
| SMA: Bullish | Nov 2, 12:30 PM | 13 hours ago |
| MACD: Buy Signal | Nov 2, 12:30 PM | 13 hours ago |
| MACD: Sell Signal | Nov 2, 10:05 AM | 16 hours ago |
| SMA: Bearish | Nov 2, 10:00 AM | 16 hours ago |
| RSI: Overbought | Oct 30, 3:55 PM | 3 days ago |
| SMA: Bullish | Oct 30, 3:25 PM | 3 days ago |
| SMA: Bearish | Oct 30, 3:15 PM | 3 days ago |
| SMA: Bullish | Oct 30, 3:05 PM | 3 days ago |
| MACD: Buy Signal | Oct 30, 2:50 PM | 3 days ago |
| MACD: Sell Signal | Oct 30, 2:20 PM | 3 days ago |
| MACD: Buy Signal | Oct 30, 2:15 PM | 3 days ago |
| MACD: Sell Signal | Oct 30, 2:05 PM | 3 days ago |
| SMA: Bearish | Oct 30, 1:50 PM | 3 days ago |
| SMA: Bearish | Oct 30, 1:50 PM | 3 days ago |
| MACD: Buy Signal | Oct 30, 12:40 PM | 3 days ago |
Newest 20 of 122.
Financial health
Altman Z-Score
-18.11 Distress zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
2 / 9 Weak
Nine pass/fail tests of profitability, leverage and efficiency.
FMP rating
C2 / 5 overall
- DCF 1
- Return on Equity 1
- Return on Assets 1
- Debt / Equity 1
- P/E 1
- P/B 5
Valuation
P/E -0.3×
FY 2018 5y median -11.3× FY 2025
P/S 1.3×
FY 2018 5y median 5.4× FY 2025
P/B 0.4×
FY 2018 5y median 0.4× FY 2025
P/FCF -0.3×
FY 2018 5y median -0.6× FY 2025
EV/EBITDA -0.7×
FY 2018 5y median -0.7× FY 2025
EV/Sales 2.8×
FY 2018 5y median 6.6× FY 2025
FCF Yield -390.3%
FY 2018 5y median -164.6% FY 2025
Profitability
Gross Margin 80.6%
FY 2018 5y median -681.4% FY 2025
Operating Margin -450.1%
FY 2018 5y median -967.4% FY 2025
Net Margin -433.7%
FY 2018 5y median -878.6% FY 2025
ROE -125.9%
FY 2018 5y median -61.4% FY 2025
ROIC -67.7%
FY 2018 5y median -53.6% FY 2025
ROA -58.8%
FY 2018 5y median -43.3% FY 2025
Growth (YoY)
Revenue 0.1%
FY 2018 FY 2025
Operating Income 52.6%
FY 2018 FY 2025
EPS (diluted) -981.8%
FY 2018 FY 2025
Free Cash Flow 34.9%
FY 2018 FY 2025
Financial Health
Current Ratio 3.6×
FY 2018 5y median 5.2× FY 2025
Quick Ratio 3.6×
FY 2018 5y median 5.2× FY 2025
Debt / Equity 0.9×
FY 2018 5y median 0.2× FY 2025
Net Debt / EBITDA -0.4×
FY 2018 5y median -0.2× FY 2025
Interest Coverage 0.0×
FY 2018 5y median 0.0× FY 2025
Dividends
Dividend Yield 0.0%
FY 2018 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2018 5y median 0.0% FY 2025
Annual · latest fiscal year ends 2025-12-31
